Degenerative joint disease (DJD) Flashcards

1
Q

What is DJD?

A
  • the end stage of joint disease
  • one of the most common orthopaedic conditions vets deal with in practice
  • incurable, but ideally temporarily manageable
  • degeneration of articular cartilage
  • bone changes (OA) -new bone formation and bone lysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contents - cartilage

A
  • 75% water
  • 15% type 2 collagen
  • 8% PGs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What conditions lead to DJD? 5

A
  • TRAUMA (acute, repetitive)
  • INFECTIOUS INFLAMMATION (septic arthritis)
  • NON-INFECTIOUS INFLAMMATION
  • DEVELOPMENTAL DISEASE (dysplasia, angular limb deformity, flexural limb deformity, osteochondrosis)
  • OTHER
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline pathophysiology of DJD

A
  • AC: failure of homeostasis (cartilage breakdown products, MMPs, and catabolic cytokines (IL-1, IL-6, TNF)
  • SYNOVIAL MEMBRANE: Pgs, leukotrienes, neuropeptides, cytokines
  • SUBCHONDRAL BONE: (chronic remodelling) altered load absorption - cartilage damage, inflammatory mediators (IL-1, TNF)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What causes pain in arthritis?

A
  • no pain Rs in cartilage
  • pain Rs in joint capsule (synovitis, joint distension)
  • exposure of sunchondral bone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the role of soft tissues in cartilage degradation?

A
  • synoviocytes release mediators and enzymes (PGs, cytokines, MMPs)
  • increased levels of inflammatory mediators measured in joint fluid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How well do radiographic signs of OA correlate with CS?

A

poorly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What to look for on clinical exam

A
  • weight and BCS
  • LAMENESS EXAM:
  • ID
  • scoring
  • localise
  • palpation/manipulation of joint
  • pain/heat/ swelling/crepitus
  • joint thickening/ effusion
  • reduced ROM
  • mm atrophy
  • local analgesia
  • synovial fluid analysis (LA often unspecific)
  • diagnostic imaging: radiograph (plain/contrast), ultrasound, MRI/CT
  • arthroscopy: synovial biopsy sometimes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is more specific than peripheral nn blocks in large animals?

A

intraarticular analgesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What should you do if you have a positive digital nerve block?

A

return on 2 separate occasions to block DIPJ and the navicular bursa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List radiographic features to look for when suspecting OA - 3

A
  • osteophytes
  • soft tissues (soft tissue, effusion)
  • subchondral bone sclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Goals - arthritis tx

A
  • pain reduction
  • stop inflammation (decrease mediator secretion)
  • chondroprotection (disease modification = to arrest/slow down cartilage degeneration, but EBVM lacking)
  • established OA cannot be fully cured
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tx strategies - arthritis

A
  • weight control
  • exercise modification/ physio
  • strategic analgesia (achieve acceptable level of exercise)
  • joint supplements (nutraceuticals, disease modification)
  • novel tx concepts
  • salvage procedures (if all else fails)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tx - arthritis flare-ups - 3

A
  • initial analgesia (5-10d)
  • gradually resume controlled exercise
  • swimming/hydrotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Medical arthritis tx - large animals

A
  • NSAIDs
  • I/A corticosteroids
  • GAGs
  • sodium hyaluronate
  • supplements (chondroitin sulphate, glucosamine)
  • IL-1 antagonist protein
  • Tiludronate (Tildren): selected conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do corticosteroids block?

A
  • PLPA2 (i.e. pain, swelling, cartilage degradation, heat)
  • COX
  • cartilage-degrading enzymes (MMP-13,3,1 and aggrecanase 1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What do NSAIDs block?

A

COX

18
Q

What is commonest medication for orthopaedic problems?

A

NSAIDs (cheap adn efficient)

19
Q

Side effects - NSAIDs

A
  • GI ulcer
  • nephritis (with sensitive animals)
  • PLE (with chronic ulcers)
  • negative influence on cartilage and bone metabolism
20
Q

Why is ketoprofen popular in horses?

A

because more COX1 selective in horses. used often in foals, v expensive in adults because of dose required

21
Q

Outline corticosteroids in tx of arthritis

A
  • often in horses

- most potent anti-inflammatory drugs (inflammatory cells and humoral mediators)

22
Q

Side effects- IA corticosteroids

A
  • negative effects on cartilage metabolism and healing
  • data controversial
  • decreased PG synthesis and organisation
  • increased risk of iatrogenic joint infections (temporary shut down of inflammatory defence mechanisms)
  • laminitis?
23
Q

What dictates drug choice and dose? 4

A
  • joint volume
  • severity of inflammation
  • # joints to tx
  • personal preference
24
Q

List options for IA corticosteroids

A
  • bethamethasone
  • triamcinolone acetonide
  • flumethasone
  • isoflupedone acetate
  • methylprednisolone acetate
25
Q

Describe mechanism of polysulphated GAGs in horses - 3

A
  • MMP inhibition
  • stimulates HA production
  • stimulates matrix synthesis
26
Q

Use of GAGs

A
  • higher concentration
  • increased risk of sepsis
  • non-septic inflammation (flare)
  • licensing
  • only licensed for IM injection (use higher dose if going IA)
27
Q

Name 2 types of GAG used in horses for arthritis

A
  • polysulphated GAGs (Adequan) = from bovine lung and trachea
  • pentosan polysulphate (Catrophen) = from beechwood hemicellulose
28
Q

Mechanism -pentosan polysulphate

A
  • stimulates cartilage matrix synthesis
  • stimulates HA syntehsis
  • MMP inhibition
  • inhibits inflammatory mediators
  • mobilise thrombi and fibrin in synovium
  • mobilise lipids and cholesterol in BVs
  • inhibits platelet aggregation and clotting
  • increase plasma lipase levels
29
Q

Why is sodium hyaluronate good to give to horses?

A

Major structural component:
- Articular cartilage matrix (from chondrocytes)
- Synovium (by type B synoviocytes)
Anti-inflammatory function (either by steric hindrance or chemotactic response)

30
Q

Mechanism - exogenous sodium hyaluronate in horses

A
  • speculative
  • lubrication
  • anti-inflammatory activity
  • activation of cell receptors
  • supplementation of depleted endogenous HA
  • stimulation of endogenous HA synthesis
  • important that molecular weight is > 5* 10^2kDa
31
Q

Administration - sodium hyaluronate

A
  • IA
  • IV
  • Per os (unknown bioavailability)
32
Q

Mechanism - neutraceutical supplements

A
  • stimulate cartilage matrix synthesis
  • MMP inhibition
  • reduce inflammatory mediators
33
Q

Name 3 matrix GAG supplements

A
  • gluosamine (3 forms; HCl, So4, N-acetyl-D-glucosamine)
  • chondroitin sulphate (small molecules important for degradation in GIT mucosa)
  • glucosamine/ chondroitin sulphate combination (effect may be better than individual effect)
34
Q

What is green-lipped mussel extract?

A
  • from edible shellfish (NZ)
  • neutraceutical supplement
  • anti-inflammatory
  • chondroitin sulphate source
  • unique combination of fatty aas
  • minerals
  • vitamins
35
Q

What is methylsulphonylmethan (MSM)?

A
  • sulphur source (usually enough in diet) for collagen and matrix metabolsim
  • derivate from DMSO
  • mechanism: unknown, no effect on inflammation, may be analgesic in people
36
Q

What is devil’s claw?

A

= iridoid glycosides
MECHANISM: decrease inflammatory mediators in people, no EBVM. Used in traditional african medicine (arthritis, fever, skin conditions, GI disease)

37
Q

What is IRAP?

A

= IL-1 Receptor Antagonist Protein

  • for equine OA
  • directly blocks effects of IL-1
  • decreased inflammation in experimental synovitis
  • no controlled large scale clinical studies (horse)
  • therapeutic success in many cases refractory to steroids
38
Q

What does IL-1 do?

A
  • key inflammatory mediator in OA

- stimulates cartilage-degrading enzymes (MMPs, aggrecanase)

39
Q

What is ACS?

A

= Autologous Conditioned Serum

  • for equine OA
  • culture patient blood in special syringe (chromium-sulphate soaked glass beeds)
  • up-regulation of IRAP and other anti-inflammatory mediators
  • IA administration
  • serum can be stored frozen (for serial IA injections)
40
Q

What is Tiludronate (Tildren)?

A
  • non-nitrogenous biphosphonate: inhibition of bone resorption (osteoclast apoptosis), anti-inflammatory properties
  • Europe - licensed for horses, distal tarsal OA, navicular disease, side effect may be colic so give as CRI over 30 mintues
41
Q

Name surgical tx for OA

A
  • excision arthroplasty (SA + small ponies)
  • arthrodesis (horse pastern, distal tarsus, fetlock, carpus; often salvage procedure)
  • total joint replacement (SA)